| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0007 |